NCT02285816 2026-03-09
MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
Canadian Cancer Trials Group
Phase 1/2 Active not recruiting
Clinical Trials
9 trialsNCT06295367 2026-03-02
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT06410209 2026-02-27
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Children's Oncology Group
Phase 2 Recruiting
NCT06513962 2026-02-24
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Children's Oncology Group
Phase 3 Recruiting
NCT04871542 2026-02-06
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
SWOG Cancer Research Network
Recruiting
NCT03267459 2026-01-05
PREDIR
Fondation Ophtalmologique Adolphe de Rothschild
Recruiting
NCT07278739 2025-12-12
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
SWOG Cancer Research Network
Phase NA Not yet recruiting
NCT02863055 2025-09-19
NEMO
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT06078813 2025-04-30
Spine-SABR
Cancer Trials Ireland
Phase 1/2 Recruiting